Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 4
2007 1
2008 1
2009 1
2010 3
2012 2
2013 4
2015 3
2016 5
2017 5
2018 9
2019 19
2020 16
2021 7
2022 8
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG; GRID study investigators. Demetri GD, et al. Among authors: badalamenti g. Lancet. 2013 Jan 26;381(9863):295-302. doi: 10.1016/S0140-6736(12)61857-1. Epub 2012 Nov 22. Lancet. 2013. PMID: 23177515 Free PMC article. Clinical Trial.
Recent Advances in Desmoid Tumor Therapy.
Napolitano A, Mazzocca A, Spalato Ceruso M, Minelli A, Baldo F, Badalamenti G, Silletta M, Santini D, Tonini G, Incorvaia L, Vincenzi B. Napolitano A, et al. Among authors: badalamenti g. Cancers (Basel). 2020 Aug 1;12(8):2135. doi: 10.3390/cancers12082135. Cancers (Basel). 2020. PMID: 32752153 Free PMC article. Review.
CT and MR imaging of chemotherapy-induced hepatopathy.
Vernuccio F, Dioguardi Burgio M, Barbiera F, Cusmà S, Badalamenti G, Midiri M, Vilgrain V, Brancatelli G. Vernuccio F, et al. Among authors: badalamenti g. Abdom Radiol (NY). 2019 Oct;44(10):3312-3324. doi: 10.1007/s00261-019-02193-y. Abdom Radiol (NY). 2019. PMID: 31435760 Review.
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?
Incorvaia L, Perez A, Marchetti C, Brando C, Gristina V, Cancelliere D, Pivetti A, Contino S, Di Giovanni E, Barraco N, Bono M, Giurintano A, Bazan Russo TD, Gottardo A, Cutaia S, Pedone E, Peri M, Corsini LR, Fanale D, Galvano A, Scambia G, Badalamenti G, Russo A, Bazan V. Incorvaia L, et al. Among authors: badalamenti g. Cancer Treat Rev. 2023 Dec;121:102650. doi: 10.1016/j.ctrv.2023.102650. Epub 2023 Oct 31. Cancer Treat Rev. 2023. PMID: 37939446 Free article. Review.
The significance of tissue-agnostic biomarkers in solid tumors: the more the merrier?
Gristina V, Pisapia P, Barraco N, Pepe F, Iacono F, La Mantia M, Peri M, Galvano A, Incorvaia L, Badalamenti G, Bazan V, Troncone G, Russo A, Malapelle U. Gristina V, et al. Among authors: badalamenti g. Expert Rev Mol Diagn. 2023 Jul-Dec;23(10):851-861. doi: 10.1080/14737159.2023.2245752. Epub 2023 Aug 8. Expert Rev Mol Diagn. 2023. PMID: 37552548 Review.
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.
Gounder MM, Razak AA, Somaiah N, Chawla S, Martin-Broto J, Grignani G, Schuetze SM, Vincenzi B, Wagner AJ, Chmielowski B, Jones RL, Riedel RF, Stacchiotti S, Loggers ET, Ganjoo KN, Le Cesne A, Italiano A, Garcia Del Muro X, Burgess M, Piperno-Neumann S, Ryan C, Mulcahy MF, Forscher C, Penel N, Okuno S, Elias A, Hartner L, Philip T, Alcindor T, Kasper B, Reichardt P, Lapeire L, Blay JY, Chevreau C, Valverde Morales CM, Schwartz GK, Chen JL, Deshpande H, Davis EJ, Nicholas G, Gröschel S, Hatcher H, Duffaud F, Herráez AC, Beveridge RD, Badalamenti G, Eriksson M, Meyer C, von Mehren M, Van Tine BA, Götze K, Mazzeo F, Yakobson A, Zick A, Lee A, Gonzalez AE, Napolitano A, Dickson MA, Michel D, Meng C, Li L, Liu J, Ben-Shahar O, Van Domelen DR, Walker CJ, Chang H, Landesman Y, Shah JJ, Shacham S, Kauffman MG, Attia S. Gounder MM, et al. Among authors: badalamenti g. J Clin Oncol. 2022 Aug 1;40(22):2479-2490. doi: 10.1200/JCO.21.01829. Epub 2022 Apr 8. J Clin Oncol. 2022. PMID: 35394800 Free PMC article. Clinical Trial.
Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond.
Di Lisi D, Madonna R, Zito C, Bronte E, Badalamenti G, Parrella P, Monte I, Tocchetti CG, Russo A, Novo G. Di Lisi D, et al. Among authors: badalamenti g. Int J Cardiol. 2017 Jan 15;227:11-17. doi: 10.1016/j.ijcard.2016.11.174. Epub 2016 Nov 9. Int J Cardiol. 2017. PMID: 27866063 Review.
A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST).
Cappello G, Giannini V, Cannella R, Tabone E, Ambrosini I, Molea F, Damiani N, Landolfi I, Serra G, Porrello G, Gozzo C, Incorvaia L, Badalamenti G, Grignani G, Merlini A, D'Ambrosio L, Bartolotta TV, Regge D. Cappello G, et al. Among authors: badalamenti g. Eur J Radiol Open. 2023 Jul 10;11:100505. doi: 10.1016/j.ejro.2023.100505. eCollection 2023 Dec. Eur J Radiol Open. 2023. PMID: 37484979 Free PMC article.
Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis.
Norata D, Peri M, Giammalva GR, Lupica A, Paolini F, Incorvaia L, Badalamenti G, Gristina V, Galvano A, Russo A, Iacopino DG, Silvestrini M, Bazan V, Brighina F, Di Stefano V. Norata D, et al. Among authors: badalamenti g. Diagnostics (Basel). 2023 Jan 1;13(1):144. doi: 10.3390/diagnostics13010144. Diagnostics (Basel). 2023. PMID: 36611440 Free PMC article. Review.
97 results